Calcitonin increases the concentration of insulin-like growth factors in serum-free cultures of human osteoblast-line cells

Calcified Tissue International

Volumn 67, Issue 3, 2000, Pages 247-254

  Farley, J ^a   Dimai, H P ^b   Stilt Coffing, B ^b   Farley, P ^b   Pham, T ^b   Mohan, S ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Jerry L Pettis Memorial VA Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; SALCATONIN; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

ARTICLE; BONE DENSITY; CALCIUM TRANSPORT; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; HORMONAL REGULATION; HUMAN; HUMAN CELL; OSTEOBLAST; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ALKALINE PHOSPHATASE; CALCITONIN; CALCIUM; CULTURE MEDIA, SERUM-FREE; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; OSTEOBLASTS; OSTEOSARCOMA; THYMIDINE; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0033901747     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002230001112     Document Type: Article

References (74)

1. Thyrocalcitonin, inhibitor of bone resorption in tissue culture
2. Chemistry, physiology and therapeutic applications of calcitonin
3. Calcitonin, physiology and patho-physiology
4. The effects of parathyroid hormone, colchicine and calcitonin on the ultrastructure and activity of osteoclasts in organ culture
5. The sensitivity of isolated osteoclasts to morphological transformation by calcitonin
6. Early effects of parathyroid hormone and calcitonin on the number of osteoclasts and on serum calcium in rats
7. A comparative study of disaggregated chick and rat osteoclasts in vitro: Effects of calcitonin and prostaglandins
8. Abundant calcitonin receptors in isolated rat osteoclasts
9. The effects of calcitonin on cartilage growth
10. Acute effects of calcitonin on bone formation in man
11. The effects of calcitonin on bone formation
12. Acute effects of calcitonin on bone formation in man
13. Effect of calcitonin administration on young pig trabecular bone remodeling
14. Two biochemical indices of mouse bone formation are increased in vivo in response to calcitonin
15. The anti-bone-resorptive agent calcitonin also acts in vitro to directly increase bone formation and bone cell proliferation
16. Response of osteoblastic clonal cell line (MC3T3-E1) to eel calcitonin at a specific cell density or differentiation stage
17. Characterization of an osteoblast-like clonal cell line which responds to both parathyroid hormone and calcitonin
18. Calcitonin stimulates growth and maturation of embryonic chick pelvic cartilage in vitro
19. Calcitonin (but not calcitonin gene-related-peptide) increases mouse bone cell proliferation in a dose-dependent manner, and mouse bone formation, alone and in combination with fluoride
20. Immunocytochemical evidence for endogenous calcitonin and PTH in osteoblasts from the calvaria of neonatal mice
21. Immunohistochemical demonstration of calcitonin binding to specific cell types in fixed rat bone tissue
22. Direct in vivo demonstration by autoradiography of specific binding sites for calcitonin in skeletal and renal tissues of the rat
23. Calcitonin stimulates cAMP and Ca second messenger generation and reverses PTH suppression of DNA synthesis in UMR-106 osteoblast-like cells
24. 3[H]-thymidine incorporation and alkaline phosphatase activity in human osteoblast-line cells
25. Mitogenic responsiveness of human bone cells to hormones and growth factors decreases with age
26. 45Ca uptake and alters alkaline phosphatase specific activity in human osteosarcoma cells
27. Calcitonin acutely increases tyrosylphosphorylation of proteins in human osteosarcoma (SaOS-2) cells
28. Insulin-like growth factors and bone: The osteoporosis connection
29. Skeletal growth factors
30. The insulin-like growth factor system and the coupling of formation to resorption
31. Regulation of insulin-like growth factor system components by osteogenic protein-1 in human bone cells
32. Progesterone and promegestone stimulate human bone cell proliferation and insulin-like growth factor-2 production
33. Low amplitude, low-frequency electric field-stimulated bone cell proliferation may be in part mediated by increased IGF-II release
34. Calcitonin stimulates the transcript and polypeptide levels of insulin-like growth factor 1 in the fibroblast/preosteoblast fraction of primary bone cell cultures
35. Insulin-like growth factor binding protein-4 (IGFGBP-4) inhibits both basal and IGF-mediated chick pelvic cartilage growth in vitro
36. 3 increases secretion of insulin-like growth factor binding protein-4 (IGFBP-4) by human osteoblast-like cells in vitro and elevates IGFBP-4 serum levels in vivo
37. Studies on the mechanisms by which insulin-like growth factor (IGF) binding protein-4 (IGFBP-4) and IGFBP-5 modulate IGF actions in bone cells
38. Evidence that osteogenic protein-1 (OP-1/ BMP-7) recruits the IGF, TGF-β, and BMP systems to mediate its pleotropic actions
39. Evidence for a role for insulin-like growth factor binding proteins in glucocorticoid inhibition of normal human osteoblast-like cell proliferation
40. Retinoic acid regulates insulin-like growth factor binding protein-4 (IGFBP-4) expression in human osteoblast cells
41. Characterization of a human osteosarcoma cell line (SaOS-2) with osteoblastic properties
42. Characterization of a human osteoblastic osteosarcoma cell line (SaOS-2) with high bone alkaline phosphatase activity
43. Alkaline phosphatase activity from human osteosarcoma cell line SaOS-2: An isoenzyme standard for quantifying skeletal alkaline phosphatase activity in serum
44. Skeletal alkaline phosphatase specific activity is an index of the osteoblastic phenotype in subpopulations of the human osteosarcoma cell line SaOS-2
45. Characterization of cells isolated and cultured from human bone
46. 2-vitamin D
47. Recombinant synthesis of insulin-like growth factor binding protein-4 (IGFBP-4): Development, validation, and application of a radioimmunoassay for IGFBP-4 in human serum and other biological fluids
48. Development, validation and application of a radioimmunoassay for insulin-like growth factor binding protein-5 in human serum and other biological fluids
49. Structure-function analysis of the human insulin-like growth factor (IGF) binding protein (hIGFBP)-4
50. A rapid and sensitive method for quantitation of microgram amounts of protein using the principle of protein-dye binding
51. 45Ca uptake by SaOS-2 cells: The effect is phosphate dependent
52. 18 Sep-Pak separation
53. Development of valid methods to measure insulin-like growth factor-I and II in bone cell conditioned medium
54. Insulin-like growth factor (IGF)-1, -2, IGF binding proteins (IGFBP)-3, -4, -5 levels in the conditioned media of normal human bone cells are skeletal site-dependent
55. Studies on the regulation of insulin-like growth factor binding protein-3 secretion in human osteosarcoma cells in vitro
56. The neuropeptide calcitonin gene-related peptide stimulates insulin-like growth factor I production by primary fetal rat osteoblasts
57. Calcitonin gene-related peptide enhances bone colony development in vitro
58. Targeted expression of calcitonin gene-related peptide to osteoblasts increases bone density in mice
59. Amylin stimulates osteoblast proliferation and increases mineralized bone volume in adult mice
60. Effects of amylin on human osteoblast-like cells
61. Systemic administration of amylin increases bone mass, linear growth, and adiposity in adult male mice
62. Aymlin, calcitonin gene-related peptide, calcitonin, and adrenomedullin: A peptide superfamily
63. Diabetogenic effects of salmon calcitonin are attributable to amylin-like activity
64. Calcitonin acts upon two receptor subtypes on the osteoclast: The 'amylin-site' and the 'calcitonin site'
65. Identification of multiple human calcitonin receptor isoforms: Heterologous expression and pharmacological characterization
66. Expression cloning and receptor pharmacology of human calcitonin receptors from MCF-7 cells and their relationship to amylin receptors
67. Molecular pharmacology of receptors for calcitonin-gene-related peptide, amylin and adrenomedullin
68. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor
69. A receptor activity modifying protein (RAMP)2-dependent adrenomedullin receptor is a calcitonin gene-related peptide receptor when coexpressed with human RAMP1
70. An amylin receptor is revealed following co-trans-fection of a calcitonin receptor with receptor activity modifying proteins-1 or -3
71. Polymorphisms of the calcitonin receptor gene are associated with bone mineral density in postmenopausal Italian women
72. Calcitonin receptor polymorphism is associated with a decreased fracture risk in post-menopausal women